Kala Bio (KALA) Current Assets (2016 - 2026)
Kala Bio (KALA) reported Current Assets of $10.58 million for Q2 2026, down 68.6% from $33.66 million a year earlier and down 14.1% from the prior quarter.
Powered by 
Analysis
Kala Bio (KALA) Current Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Kala Bio posted Current Assets of $9.49 million, down 82.0% from FY2024.
- Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -43.9% (FY2020 to FY2025).
- By year, Current Assets came in at $52.8 million in FY2024 (-0.1%), $52.87 million in FY2023 (-38.5%), $85.94 million in FY2022 (-30.9%) and $124.37 million in FY2021 (-27.4%).
- Five-year quarterly Current Assets spans a low of $9.49 million in Q4 2025 and a high of $149.09 million in Q3 2021.
- Year over year, Current Assets has now declined in each of the last 22 quarters, with an average decline of 42.4% over the last eight quarters.
- The year-over-year decline in Current Assets has ranged between 0.1% (Q4 2024) and 82.0% (Q4 2025) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $12.32 million (Q1 2026), $9.49 million (Q4 2025) and $24.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Kala Bio | 6.57 Mn | 6.57 Mn | - | 10.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.58 Mn |
| Mar 31, 2026 | 12.32 Mn |
| Dec 31, 2025 | 9.49 Mn |
| Sep 30, 2025 | 24.27 Mn |
| Jun 30, 2025 | 33.66 Mn |
| Mar 31, 2025 | 45.72 Mn |
| Dec 31, 2024 | 52.80 Mn |
| Sep 30, 2024 | 51.28 Mn |
| Jun 30, 2024 | 58.85 Mn |
| Mar 31, 2024 | 50.09 Mn |
| Dec 31, 2023 | 52.87 Mn |
| Sep 30, 2023 | 57.90 Mn |
| Jun 30, 2023 | 65.54 Mn |
| Mar 31, 2023 | 71.34 Mn |
| Dec 31, 2022 | 85.94 Mn |
| Sep 30, 2022 | 84.67 Mn |
| Jun 30, 2022 | 83.52 Mn |
| Mar 31, 2022 | 98.26 Mn |
| Dec 31, 2021 | 124.37 Mn |
| Sep 30, 2021 | 149.09 Mn |
API Access
Kala Bio Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=KALA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "KALA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=KALA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();